Mark Reynolds Email

CFO . GeoVax

Current Roles

Employees:
32
Revenue:
$2.5M
About
GeoVax is a Biotechnology company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus - AIDS) and other infectious agents. Our goals include: developing AIDS vaccines for global markets, manufacturing and testing these vaccines under GMP/GLP conditions (FDA guidelines), conducting phase I/II and III human trials for vaccine safety and effectiveness and obtaining regulatory approval of these vaccines in the USA and specified international markets. Outstanding preclinical results: GeoVax DNA/MVA vaccine protected 96% of non-human primates for over 3½ yrs. To our knowledge, this level of protection has not been achieved by other candidate vaccines.
GeoVax Address
1900 Lake Park Drive
Smyrna, GA
United States
GeoVax Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.